cis-4-Carbomethoxycyclohexane-1-carboxylic acid, 97.0%, 5g

3,6-Difluoro-2-hydroxybenzaldehyde, 97.0%, 25g

1-(1-Methylpiperidin-2-yl)ethane-1,2-diol, 100mg

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 25g

3-Bromo-6-chloro-1H-pyrrolo[3,2-c]pyridine, 95.0%, 1g

Nitromethan, min. 98,5 %, zur Synthese, 500 ml, Glasverpackung

3-cyclopropyl-3-hydroxy-1-phenylprop-2-en-1-one, 98%, 100mg

N1,N1,N6,N6-Tetramethyladipamide, 95.0%, 100mg

2,5-Dioxopyrrolidin-1-yl acrylate, 97.00%, 100g

1-Chloro-4-methanesulfonylbutane, 95%, 250mg

2-Amino-6-bromobenzoic acid, 97.0%, 25g

(2s)-2-[4-(trifluoromethyl)phenyl]morpholine, 98%, 500mg

Sodium Ethylxanthate>97.0%(T)500g